Canada-based Aurora Cannabis Inc (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) has named Dr Jonathan Page, PhD as its new chief science officer, it was reported yesterday.
In this new role, Dr Page will manage all science-related projects at the company.
Dr Page is a cannabis scientist, with 37 peer-reviewed publications, who was the co-lead of the Canadian team of scientists who first sequenced the cannabis genome. Prior to his appointment, Dr Page served as CEO of recently acquired Anandia Labs. An entrepreneurial scientist, Dr Page co-founded Anandia Labs. He is an adjunct professor in the Botany Department at the University of British Columbia, who received his PhD from UBC, undertook postdoctoral training in Germany, and for a decade directed a lab at the National Research Council. He is also an inventor with eight issued patents or patent applications, and a frequent lecturer on cannabis science at international conferences.
CEO Terry Booth, said, 'We are thrilled to have Jonathan join the Aurora team as chief science officer. Jonathan's knowledge of the cannabis plant and its applications make him a globally recognised leader in the cannabis sector. With this appointment we are well-positioned to continue to innovate through the research our teams are involved in and drive new commercial products.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer